Immunome, Inc. (IMNM)
USD 7.35
(3.52%)
USD 7.35
(3.52%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -7.56 Million | -28.69 Million | -18.22 Million | -12.13 Million | -9.6 Million | -7.4 Million |
| Net Income | -106.8 Million | -36.89 Million | -24.71 Million | -17.83 Million | -10.44 Million | -7.84 Million |
| Depreciation & Amortization | 728 Thousand | 631 Thousand | 755 Thousand | 755 Thousand | 615 Thousand | 521 Thousand |
| Deferred income taxes | - | -7.27 Million | -500 Thousand | 5.53 Million | - | - |
| Stock-based compensation | 6.22 Million | 5.33 Million | 3.44 Million | 621 Thousand | 14 Thousand | 11 Thousand |
| Change in working capital | 11.99 Million | 2.24 Million | 2.77 Million | -1.2 Million | 212 Thousand | -102 Thousand |
| Other non-cash items | 88.57 Million | 7.27 Million | 4000.00 | -2000.00 | 3000.00 | 9000.00 |
| Investing Cash Flow | -30.48 Million | -248 Thousand | -79 Thousand | -586 Thousand | -233 Thousand | -228 Thousand |
| Investments in PPE | -831 Thousand | -248 Thousand | -79 Thousand | -586 Thousand | -233 Thousand | -228 Thousand |
| Acquisitions | 9.27 Million | - | - | - | - | - |
| Investment purchases | -38.92 Million | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 9.27 Million | - | - | - | - | - |
| Financing Cash Flow | 116.4 Million | 32 Thousand | 27.76 Million | 49.94 Million | 10.77 Million | -551 Thousand |
| Debt repayment | - | - | -113 Thousand | -451 Thousand | -612 Thousand | -551 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | -49 Thousand | -35 Thousand | - |
| Common Stock Issuance | -8.59 Million | 32 Thousand | 27.88 Million | 44.85 Million | 4.62 Million | - |
| Other Financing Activities | 116.4 Million | 32 Thousand | 27.88 Million | 5.64 Million | 11.42 Million | - |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | -608 Thousand | -677 Thousand | 1.78 Million | 504 Thousand | 75 Thousand | 146 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | 12.6 Million | 2.92 Million | 998 Thousand | -1.71 Million | 137 Thousand | -248 Thousand |
| Cash at beginning of period | 20.32 Million | 49.32 Million | 39.86 Million | 2.64 Million | 1.7 Million | 9.88 Million |
| Cash at end of period | 98.67 Million | 20.42 Million | 49.32 Million | 39.86 Million | 2.64 Million | 1.7 Million |
| Capital Expenditure | -831 Thousand | -248 Thousand | -79 Thousand | -586 Thousand | -233 Thousand | -228 Thousand |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 78.35 Million | -28.9 Million | 9.46 Million | 37.22 Million | 941 Thousand | -8.18 Million |
| Free Cash Flow | -8.39 Million | -28.93 Million | -18.3 Million | -12.72 Million | -9.83 Million | -7.63 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -36.12 Million | -129.49 Million | -106.8 Million | -92.63 Million | -4.34 Million | -5.55 Million |
| Depreciation & Amortization | 673 Thousand | 263 Thousand | 728 Thousand | 257 Thousand | 166 Thousand | 157 Thousand |
| Deferred income taxes | - | - | - | 1.59 Million | - | -758 Thousand |
| Stock-based compensation | 3.22 Million | 2.15 Million | 6.22 Million | 2.88 Million | 1.08 Million | 1.03 Million |
| Change in working capital | 2.86 Million | 4.48 Million | 11.99 Million | -7.92 Million | -5.85 Million | -1.3 Million |
| Other non-cash items | 10.56 Million | 111.7 Million | 88.57 Million | 84.03 Million | 332 Thousand | 758 Thousand |
| Investing Cash Flow | -81.68 Million | -37.23 Million | -30.48 Million | -30 Million | -36 Thousand | -340 Thousand |
| Investments in PPE | -2.34 Million | -2.16 Million | -831 Thousand | -349 Thousand | -36 Thousand | -340 Thousand |
| Acquisitions | - | -20.06 Million | 9.27 Million | 9.27 Million | - | - |
| Investment purchases | -112.68 Million | - | -38.92 Million | -38.92 Million | - | - |
| Sales/Maturities of investments | 40 Million | - | - | - | - | - |
| Other Investing Activities | -6.65 Million | -35.06 Million | 9.27 Million | 9.27 Million | - | - |
| Financing Cash Flow | 694 Thousand | 219.44 Million | 116.4 Million | 55.49 Million | 60.87 Million | - |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 390 Thousand | -13.98 Million | -8.59 Million | -8.5 Million | -125 Thousand | - |
| Other Financing Activities | 304 Thousand | 233.42 Million | 116.4 Million | 55.49 Million | 60.87 Million | - |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | -32 Thousand | 2.39 Million | -608 Thousand | -679 Thousand | -1.2 Million | 589 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | 2.89 Million | 2.08 Million | 12.6 Million | -7.24 Million | -4.64 Million | -1.89 Million |
| Cash at beginning of period | 269.72 Million | 98.67 Million | 20.32 Million | 90.64 Million | 38.51 Million | 44.52 Million |
| Cash at end of period | 165.33 Million | 269.72 Million | 98.67 Million | 98.67 Million | 90.74 Million | 38.51 Million |
| Capital Expenditure | -2.34 Million | -2.16 Million | -831 Thousand | -349 Thousand | -36 Thousand | -340 Thousand |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -104.39 Million | 171.04 Million | 78.35 Million | 8.03 Million | 52.22 Million | -6 Million |
| Free Cash Flow | -25.74 Million | -13.33 Million | -8.39 Million | -17.8 Million | -8.65 Million | -6 Million |
SNG
APM
3300
ZENOTECH
MHUB
PANCHSHEEL